Clinical Trials Logo
  1. Home
  2. Cocaine Dependence
  3. NCT00167258
  4. Details
NCT00167258 Clinical Trial

Effectiveness and Costs of Enhanced Cocaine Treatments

Cocaine Dependence Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00167258
Other study ID # 702110
Secondary ID
Status Completed
Phase Phase 2
First received September 9, 2005
Last updated December 14, 2009
Est. completion date February 2007

Study information
Verified date December 2009
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardUniversity of Pennsylvania: IRBCity of Philadelphia: IRB
Study type Interventional

Clinical Trial Summary

The study will evaluate the effectiveness, economic benefits, and costs of voucher reinforcement for cocaine and alcohol abstinence, additional counseling services, and their combination in a sample of cocaine dependent patients receiving outpatient treatment as usual in a community clinic.

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date February 2007
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Enrollment in an intensive outpatient program (IOP) for no more than 1 month

- Current DSM-IV diagnosis of cocaine dependence (month prior to IOP treatment)

- 18-65 years of age

- Ability to provide names of informants to help locate subject for follow-up

Exclusion Criteria:

- IV heroin use in last year

- Acute medical/psychiatric diagnosis that precludes outpatient treatment

- Inpatient treatment for 6 weeks or more prior to IOP treatment

- Incarceration for 6 months or more prior to IOP treatment

Study Design

Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Behavioral:
• Voucher Reinforcement

• Extra Counseling Services

• Voucher Reinforcement + Extra Counseling Services

Locations
Country Name City State
United States University of Pennsylvania Philadelphia Pennsylvania

Sponsors (1)
Lead Sponsor Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Recruiting NCT04994821 - tDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study Phase 2
Completed NCT01402492 - Cocaine Use Reduction With Buprenorphine Phase 2/Phase 3
Completed NCT01601743 - Exercise as a Behavioral Treatment for Cocaine Dependence N/A
Completed NCT01176591 - HBPL Study of the Impact of the NK1 Antagonist Aprepitant Phase 2
Completed NCT00880997 - The Efficacy of Doxazosin for Cocaine Users Phase 1
Completed NCT00566969 - Cocaine Withdrawal and Pharmacotherapy Response N/A
Completed NCT00585520 - Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues Phase 1
Completed NCT00368290 - Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior Phase 2
Completed NCT00322309 - Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects Phase 2
Completed NCT00385801 - Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence Phase 2
Completed NCT00167245 - Topiramate for Alcohol and Cocaine Dependence Phase 2
Completed NCT00842517 - Long Term Maintenance of Drug Abstinence Phase 1
Not yet recruiting NCT05974202 - rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder Phase 2
Completed NCT04411914 - Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid Phase 1
Active, not recruiting NCT03266939 - Rebalancing the Serotonergic System in Cocaine Dependence Phase 1
Completed NCT02563769 - Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study Phase 1
Recruiting NCT06159387 - Randomized, Double-blind, Placebo-controlled Cannabis Extract x Placebo for Cocaine Addicts Phase 4
Terminated NCT02935101 - Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants Phase 2
Completed NCT02018263 - Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans Phase 1
Completed NCT01573273 - Oxytocin in Cocaine Dependence N/A